Bladder Cancer | Proceedings from a live event held adjunct to the American Urological Association’s Annual Meeting

Featuring perspectives from Drs Arjun Balar, Ashish Kamat, Guru Sonpavde and Robert Svatek, including the following topics: Personalized Continuing Medical Education Introduction (0:00) Understanding the Millennial Physician — Jason Hafron, MD (2:30) Non-Muscle-Invasive Urothelial Bladder Cancer (UBC) Case: A man in his late 70s with bacillus Calmette-Guérin (BCG)-refractory non-muscle-invasive bladder cancer — David S Morris, MD (9:27) Case: A man in his mid-60s with high-risk non-muscle-invasive UBC — Gordon A Brown, DO (14:45) Case: A man in his late 50s with high-risk, BCG-refractory non-muscle-invasive bladder cancer — Dr Hafron (23:03) Case: A man in his mid-80s with recurrent high-grade noninvasive papillary carcinoma — Dr Morris (32:16) Neoadjuvant and Adjuvant Treatment of Muscle-Invasive UBC Case: A man in his mid-80s with muscle-invasive bladder cancer who declines cystectomy — Sulfi Ibrahim, MD (37:22) Selection of Patients for Neoadjuvant Therapy — Dr Morris (44:08) Case: A man in his late 70s with Gleason 4 + 3 adenocarcinoma of the prostate and urothelial carcinoma — Dr Hafron (53:03) Treatment of Metastatic UBC Urologists’ Questions about Second- and Later-Line Therapies and Management of Side Effects — Dr Morris (1:02:11) Case: A woman in her early 70s with metastatic UBC, PD-L1 30% — Dr Ibrahim (1:09:15) Case: A woman in her mid-50s with muscle-invasive bladder cancer — Dr Brown (1:25:20) CME information and select publications